Article Text
PDFResearch ethics
Paper
Improving access to medicines: empowering patients in the quest to improve treatment for rare lethal diseases
Statistics from Altmetric.com
Footnotes
Funding The Wellcome Trust.
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Tragic choices
- Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study
- Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)
- Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
- Epidemiology of ALS in Korea using nationwide big data
- Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis plan
- Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China
- A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
- The management of motor neurone disease
- Pathophysiological insights into ALS with C9ORF72 expansions